Regenerative medicine: prenatal approaches

Area of Science:

• Regenerative Medicine
• Genomics
• Paediatric Health

Background:

• Recent advancements in genomic, stem-cell, and tissue-based technologies are driving progress in regenerative medicine.
• Congenital and incurable pediatric diseases present significant challenges requiring novel therapeutic approaches.
• Prenatal diagnostic and therapeutic strategies are emerging as critical areas of research.

Purpose of the Study:

• To review recent advances and applications of regenerative medicine relevant to pediatric patients.
• To highlight innovations in disease modeling and the development of new therapies for pediatric conditions.
• To discuss the opportunities and challenges associated with prenatal and in-utero therapeutic approaches.

Main Methods:

• Review of current literature on regenerative medicine, genomics, and stem-cell technologies.
• Analysis of noninvasive prenatal screening methods, including maternal plasma fetal DNA analysis.
• Examination of in-utero therapies such as stem-cell, gene, and gene-modified cell treatments.

Main Results:

• Genomic and stem-cell innovations have improved disease modeling and therapeutic development for pediatric disorders.
• Noninvasive prenatal testing using maternal plasma fetal DNA is becoming standard for genetic disorder screening.
• In-utero stem-cell, gene, and cell-based therapies show early promise for various pediatric conditions.

Conclusions:

• Regenerative medicine holds significant potential for treating congenital and incurable pediatric diseases.
• Prenatal and in-utero approaches offer unique therapeutic opportunities but face technical and ethical hurdles.
• Future directions include utilizing fetal cells for postnatal treatment and artificial placentas for ex-utero therapies.